Novel Remyelination Strategy for Multiple Sclerosis in the Era of Oligodendrocytopathy

Clinical Neurology - Japan
doi 10.5692/clinicalneurol.52.1351
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Societas Neurologica Japonica

Related search

Blueprint for the Development of Remyelination Medicines for Multiple Sclerosis

Clinical Neurology
Neurology
2010English

The Extracellular Matrix and Remyelination Strategies in Multiple Sclerosis

eNeuro
MedicineNeuroscience
2018English

Remyelination in Multiple Sclerosis: Realizing a Long-Standing Challenge

Expert Review of Neurotherapeutics
NeuroscienceNeurologyPharmacology
2015English

The New Era of Multiple Sclerosis Therapeutics

Neurotherapeutics
NeurologyPharmacology
2012English

Multiple Sclerosis CD49d+CD154+ as Myelin-Specific Lymphocytes Induced During Remyelination

Cells
2019English

A New Era for Immunotherapeutic Approaches in Multiple Sclerosis Treatment

Journal of Clinical Trials
2016English

Human Monoclonal Antibodies Reactive to Oligodendrocytes Promote Remyelination in a Model of Multiple Sclerosis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2000English

miRNA in Multiple Sclerosis: Search for Novel Biomarkers

Multiple Sclerosis
Neurology
2015English

Remyelination Promoting Therapies in Multiple Sclerosis Animal Models: A Systematic Review and Meta-Analysis

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy